Viewing Study NCT00372905


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-26 @ 2:08 AM
Study NCT ID: NCT00372905
Status: TERMINATED
Last Update Posted: 2019-09-04
First Post: 2006-09-06
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Sponsor: Northwestern University
Organization: